CEO Harold Naramore, MD, also denied speculation the hospital may be up for sale.
Speaking to elected officials in Alcoa, the need for staff retention is paramount because of skyrocketing costs of contract labor, Dr. Naramore said. He provided no details on potential incentives for employees, according to the report.
In November, Blount’s CFO, Jonathan Smith, said permanent staff would not get overtime and bonuses in 2023 in a bid to cut costs. The hospital group is set to lose approximately $70 million in 2022.
There have been discussions to turn the hospital into a nonprofit as opposed to a government-run system. This has led to speculation it may be up for sale.
Dr. Naramore also discussed the potential $22.5 million sale of the hospital’s Springbrook property to real estate group Montecito Medical. That talk has cooled in recent months, Dr. Naramore said in November, because of concerns Montecito has about the status of the hospital group.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
